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The self assembly of proteins; probing patchy
protein interactions†
Susan James, Michelle K. Quinn and Jennifer J. McManus*
The ability to control the self-assembly of biological molecules to form defined structures, with a high
degree of predictability is a central aim for soft matter science and synthetic biology. Several examples of
this are known for synthetic systems, such as anisotropic colloids. However, for biomacromolecules, such
as proteins, success has been more limited, since aeolotopic (or anisotropic) interactions between protein
molecules are not easily predicted. We have created three double mutants of human gD-crystallin for
which the phase diagrams for singly mutated proteins can be used to predict the behavior of the double
mutants. These proteins provide a robust mechanism to examine the kinetic and thermodynamic
properties of proteins in which competing interactions exist due to the anisotropic or patchy nature of the
protein surface.
Introduction
While there is increasing awareness about how best to screen
solution conditions to increase the probability of protein
crystallization, mostly, this is unsuccessful, since protein–protein
interactions are strongly determined by the specific chemistry of
the surface amino acids. Using a phase diagram approach, three
double mutant proteins of human gamma D-crystallin have been
created. In this way, the competitive nature of these anisotropic
protein interactions can be examined. For these mutants, the
behavior of the double mutants can be qualitatively predicted by
the single mutant variants, and in one case, two crystals for the
same protein were formed, each with opposite temperature
dependence of the solubility lines; one melts when it’s heated
and one melts when it’s cooled.
Anisotropic interactions are ubiquitous in nature, responsible
for the formation of lipid membranes,1 viruses2 and protein
assemblies.3 Recently, this biologically inspired anisotropy has been
exploited for the controlled self-assembly of DNA-functionalized
colloids.4,5 The controlled self-assembly of soft materials including
nanoparticles,6 colloids4 and biomacromolecules7 is a fundamental
theme in soft matter science and has generated new structures with
important applications in photonics, as catalytic supports and as
biomaterials.8,9 The degree to which self assembly can be controlled
is greatly improved by using anisotropic particles.
These anisotropic, or ‘‘patchy’’ particles, may be anisotropic in
shape,10–13 surface charge density,14 size ratio15 or have surface
functionality.4,8 Anisotropy is central to protein self assembly.16
The self-assembly of proteins is important for both protein
folding17 and in the assembly of higher order structures.18 The
formation of higher order protein assemblies includes virus
formation,19 assemblies required for normal protein function
and condensed phases that occur during the pathogenesis of
several protein condensation diseases.20 However, despite
many decades of research, we are not yet at the point where
predictable control of protein self-assembly occurs and this is
most apparent in the limited success of protein crystallization
which, for many classes of protein remains elusive.21
Protein phase diagrams map the physical state of a protein for
a range of solution conditions21 and in many ways this behavior
is similar to phase diagrams for colloidal particles.22,23 A more
complete analysis of protein phase behavior however must
include anisotropic (or aeolotopic) interactions between protein
particles to accurately describe the experimentally observed
behavior.24,25 While the protein surface is inherently patchy or
anisotropic due to the variation in its surface chemistry from
different amino acids, in some cases, an averaged net inter-protein
interaction potential is enough to explain protein behaviour.
However, in many cases, this is insufficient since, at particular
positions on the protein surface, specific amino acids (or groups
of amino acids) contribute more to the behavior of the protein
than others, which is not captured in an isotropic interaction
potential. Therefore, it is convenient to think of the protein
consisting of a number of patches (corresponding to either a
single amino acid, or a group of amino acids) giving rise to an
anisotropic interaction potential. Several aeolotopic, or ‘‘patchy’’
particle models have been developed to describe the directional
nature of protein interactions25–28 and the process of protein
self-assembly to form protein condensed states;25,29 however,
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predictable protein phase behavior has yet to materialize
experimentally.
Human gD-crystallin (HGD) is one of the most important
structural proteins found in the eye-lens. The phase behavior for
HGD is defined by net attractive short-range interactions responsible
for liquid–liquid phase separation and crystallization.30,31 HGD does
not spontaneously crystallize. One of the speculated reasons is that
the directional interactions of proteins are not compatible with
simple crystal lattices.27 However, several known single amino acid
substitutions of HGD result in proteins that crystallize readily with
significantly lower solubility than for the native protein.31 Such
single mutants of HGD are associated with congenital cataracts.30,31
A second type of single amino acid substitution in HGD at position
23 (P23V, P23T, P23S) inverts the temperature dependence of the
solubility line leading to unusual phase behavior.32–34
Given the large number of single point mutants for HGD,
which are known to alter the phase behavior of the protein, we
can use this as a model to further probe how changes to surface
amino acids in specific locations (and hence protein anisotropy)
contributes to the behavior of the resulting protein. In the
simplest case, a single amino acid substitution is used. For
HGD, a number of these have been previously described.31,32 To
increase complexity, we have instead introduced two mutations
to the same protein. Both mutations have been demonstrated to
give rise to distinctly different phase behaviours. In this case, by
mapping the behavior of this new protein, we can clearly identify
if characteristics of the original single mutant proteins are
maintained and, furthermore, if the positions of the phase
boundaries associated with the single mutations are the same in
the double mutant. Using the characteristics of these individual
single mutants, we have created three double mutants of HGD
incorporating two distinct properties; (1) inverted solubility and (2)
propensity to crystallize.
We find that the position of the liquidus phase boundary for
each of the single mutants, predicts both equilibrium and
kinetic properties of the double mutants formed. In all cases,
the double mutant protein retains its secondary structure and
crystallizes after mutagenesis. Additionally, two different crystal
types are observed for one of these new proteins, each with
opposite temperature dependence of the solubility line. These
fascinating observations are important in their own right, but
this approach may be seen as a strategy for exploring the degree
to which aeolotopic interactions are responsible for protein self-
assembly and crystallization experimentally.
Results and discussion
Phase diagrams of double mutants
The R36S single mutant of HGD crystallizes spontaneously at
significantly lower concentrations than the native protein.31
While arginine 36 is not a crystal contact point in the native
protein, it becomes one in the mutant, resulting in this
behavior.35,36 Replacing proline at position 23 inverts the
temperature dependence of the solubility line, i.e. the protein
forms aggregates/crystals at higher temperatures, which melt as
the temperature is lowered, but is not a crystal contact point in
either the native or single mutant protein.32,37 The first double
mutant of HGD that we have created, P23VR36S, incorporates
both types of mutant. CD spectroscopy measurements confirm
that no significant change in protein secondary structure (Fig. S1,
ESI†) or tertiary structure (Fig. S2, ESI†) occurs uponmutagenesis.
Furthermore, the double mutant protein forms protein crystals,
consistent with the behavior of the single mutant R36S (Fig. 1A).
In fact, the equilibrium solubility lines for R36S and P23VR36S
overlap (Fig. 1B).
The temperature dependence of the solubility line is normal
and not inverted. Hence, the behaviours associated with the
P23V mutation are suppressed in this double mutant. This is at
first not surprising and can be expected from the phase
behavior of the single mutants. The solubility line associated
with the P23V mutant occurs at significantly higher concentra-
tions than it is possible to obtain for this double mutant, since
crystallization occurs at low protein concentrations and on
short timescales. This initial mutant provides useful insights;
Fig. 1 Crystal formation for mutants of human gamma D crystallin. When
two mutants with distinct phase behavior are incorporated in one double
mutant, its phase behavior is predicted by that of the single mutants. Top:
(A1) microscopy image for the crystals formed by the single mutant R36S.
(A2) Crystals formed by the double mutant P23VR36S. Both crystal types
have the same morphology. (B) Phase diagram for the two single mutants
of HGD, R36S and P23V (black lines) and the double mutant P23VR36S
(blue). Liquidus lines for all three mutants are shown. Data for the
previously described mutants P23V and R36S is taken from ref. 30 and
32 respectively. R36S crystals have normal solubility, while P23V mutants
exhibit an inverse temperature dependence of the solubility line. The
double mutant crystal shows only normal temperature dependence
(arrows indicate the temperature change required for crystal melting).
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that the double mutants are soluble, retain their native structure
and that they crystallize in a similar way to one of the parent
single mutants. However, it also raises a number of questions.
The phase behavior of the P23V single mutant is unusual. The
co-existence curves (liquid–liquid phase separation) for both the
native and mutant proteins overlap, indicating that there is little
difference in the net-interaction potential between the two
proteins. The inverted solubility observed was explained in terms
of aeolotopic interactions, which were only engaged in the solid
phase. Here however, this amino acid substitution is present in
the double mutant and the solid phase formed has normal
solubility. The behavior associated with the P23V substitution
is not engaged at all. While the phase behavior of this initial
double mutant is consistent with the phase diagrams for each of
the parent single mutants, a number of questions remain.
Hence, we created a second double mutant.
The P23T mutant of HGD was used for the second double
mutant, since it exhibits the same inverse temperature dependence
of the solubility line, but at significantly lower concentrations than
for P23V. The double mutant incorporating this and the R36S
propensity to crystallize (P23TR36S) also maintains its secondary
structure after mutagenesis (Fig. S1, ESI†). In this case, two
different protein crystal morphologies occur for this one double
mutant protein; one, a rod shaped crystal, which has normal
temperature dependence and a second, with rhombic shaped
crystals that have inverted solubility (Fig. 2A). Again, in this
case, the equilibrium solubility lines for the single mutants are
similar to those for each of the crystal types formed in the
double mutant, and in many ways are qualitatively predictable
(Fig. 2B), with the liquidus line for the rhombic shaped crystals
consistent with that for the P23T single mutant and the rod
shaped crystals consistent with the R36S solubility line.
Interestingly, neither crystal type is morphologically similar
to the P23VR36S double mutant described earlier. Indeed, both
crystal types form spontaneously. This is noteworthy, since the
P23T single mutant forms aggregates far more easily than
crystals. In fact, the solubility line for the single mutant of
P23T actually represents a monomer–aggregate equilibrium.32
However, for the double mutant, only crystals were observed.
There is a temperature region E303 K (30 1C) on the phase
diagram where the two different crystal morphologies co-exist
(Fig. 2B). This observation is unprecedented in that the protein
exhibiting this behavior was essentially predetermined by the
behavior of the single mutants.
As a final step, a third mutant type was created, P23VR58H.
Again, this mutant incorporates a single amino acid substitution
Fig. 2 One protein, two crystals. The phase behaviour for the double mutant P23TR36S is fully described by that for the parent single mutants. In this
case, two distinct crystal types with well-defined morphologies are formed; rod shaped crystals, with normal temperature dependence of the solubility
line (A1) and rhombic shaped crystals with inverse temperature dependence of the solubility line (A2). Polarization microscopy images are shown in each
case, confirming crystal formation. The phase diagram, showing liquidus lines for both single mutants and newly formed double mutant, again indicate
that the parent single mutants are predictive of the equilibrium solubility lines for the double mutant (B). Furthermore, co-existence of both crystal types
is observed at E303 K (30 1C) (A3).
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associated with inverted solubility and a second associated with
crystallization. The R58H single mutant crystallizes with a
liquidus line almost identical to R36S, however the protein
has significantly higher solubility (up to 100 mg ml1) and
crystallization occurs more slowly.31 Unlike the R36S mutant,
position 58 is a crystal contact in the native protein but the
strength of the contact at this position actually decreases upon
mutagenesis.36 Like the other double mutants, P23VR58H
maintains its secondary structure after mutagenesis. All three
known single mutations at site 23 of HGD form large aggregates
which co-exist with protein monomer with an inverted solubility
line.32 P23T and P23V have been shown to crystallize33,37 and the
crystal–monomer solubility line appears to overlap with the
aggregate-monomer solubility line.33 The P23VR58H double
mutant also forms large aggregates as the protein is concen-
trated at temperatures above the expected solubility line for a
P23V mutant. However, over time (6 h–1 day depending on the
temperature), crystallization of protein occurs on the surface of
the aggregates which form immediately after the solubility limit
is reached (Fig. 3A).
After the formation of protein aggregates (which have
inverted solubility), the concentration of monomer in solution
decreases but is still sufficiently high to allow protein crystal
formation (due to the R58H amino acid substitution). If we
attempt to measure the liquidus line for this double mutant we
find that both aggregates and crystals co-exist and the solid
(crystal + aggregates)  liquid (monomer) equilibrium occurs at
concentrations between those expected for the individual single
mutants (Fig. 3B). The position of this ‘‘equilibrium’’ line
moves depending on the temperature at which initial aggregate
formation occurs (i.e. how much material is sequestered as
aggregates before the onset of crystallization). When less aggrega-
tion occurs at lower temperatures, increasing numbers of crystals
are formed and the ‘‘liquidus’’ linemoves to lower concentrations,
closer to that of the single R58H mutant. Indeed, it is possible to
suppress aggregate formation by keeping the concentration of
protein below the solubility line for the P23Vmutant and allowing
protein crystallization to occur (Fig. 4).
Analysis of the solubility data
If we analyse the data further, some interesting observations
emerge. In previous work, the transfer chemical potential for
the closely related single mutants, P23T, P23S and P23V was
calculated from the solubility data (based on the monomer–
aggregate solubility line).33
We use the same method here to probe if indeed the phase
boundaries for the double mutants are quantitatively the same,
i.e. is the binding energy for the crystals in the double mutants
the same as for the single mutant variant which gives rise to a
specific behavior. The transfer chemical potential, Dmtrans for
the double mutant proteins have been estimated from their
liquidus/solubility lines as described previously.33 In brief, the
Fig. 3 The battle between aggregates and crystals. (A) The third double mutant, P23VR58H exhibits both distinctive behaviours of the parent single
mutants, however both condensed phases form under the same solution conditions, but with different kinetics, leading to a hybrid structure where
protein aggregates (due to the P23V mutation) become encased in protein crystals (formed after aggregate formation, due to the R58H mutation). The
crystalline nature of the surface structures was confirmed by polarization microscopy (inset). (B) The equilibrium solubility line for the aggregate/crystal
structure lies between that for the parent single mutants P23V32 and R58H.30 Arrows indicate the solid (crystal, aggregate) to liquid (monomer) transition.
Fig. 4 Phase diagram for P23VR58H double mutant displaying shifts in the
solubility line depending on the temperature at which initial aggregates/
crystals were formed in solution.
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van’t Hoff law relates the volume fraction, f, along the solu-
bility line to the transfer chemical potential, Dmtrans by:
lnf ¼ Dmtrans
kT
(1)
By defining a value X = T0/T and T0 = 303 K (the temperature at
which the solubility lines for the R36S and P23T single mutants
intersect), and including the second virial coefficient B2 =
4[(ee  1)(l3  1)  1] defined by Lomakin et al.,25 where
e = eeff/kT from the LLPS for HGD, l = 1.25 and eeff/kTc = 1.27, the
solubility line at low volume fractions (f o B0.02), becomes:
j D j0 exp[(V  S)Dt] (2)
where
f0 ¼ exp
Dmtrans T0ð Þ
kT0
 
(3)
and V = Dmtrans(T0)/kT0; S = [q(Dmtrans/kT0)qt]t=1; and Dt = (T T0)/T0.
Using the solubility data for the native and doublemutant proteins,
the transfer chemical potential Dmtrans for each protein was
determined. Plotting Dmtrans/kT0 vs. T/T0, we find that the slope
is negative for proteins displaying normal solubility and positive
for inverted solubility and is determined by the sign of the value
K = ([Dmtrans(T0)/kT0]  S) (Fig. 5).
If we examine the solubility data, we see that the liquidus
line for the R36S and the P23VR36S mutants both qualitatively
and quantitatively overlap (Fig. 1B and Table 1). There are two
competing contributions to the protein behaviour and in this
case the R36S mutation dominates this behavior. The values for
V for both the single and double mutants are almost the same
(V = 6.9 and 6.8 respectively). No evidence of inverted solubility
is present.
For the P23TR36S mutant, several interesting observations
are made. The solubility line for the R36S-type crystal indicates
that there is a slight shift in the position of the liquidus line to
higher concentrations in the double mutant protein, due to a
change in binding energyE0.4kT (at 303 K). Therefore the P23T
mutation is influencing the position of the phase boundary for
the R36S-type crystal in the double mutant. For the crystal with
inverted solubility, there is a small change in the value of V between
the single (P23T) mutant and the double mutant of E0.2kT
(at 303 K), but in this case only crystals are observed whereas
for the single mutant, aggregation occurs more frequently. This
small change in binding energy is unlikely to fully explain this
difference in behavior and suggests some influence from the
R36S substitution.
Crystallization vs. aggregation
In the third double mutant the solubility line (or lines) represents
three co-existing protein forms; monomer, aggregate and crystal,
hence a solubility line analysis cannot provide any useful insights
and only a qualitative analysis is possible. It is significant however
that both crystals and aggregates co-exist. Thermodynamically,
the R58H crystal should be the lowest energy phase for the protein
(lowest solubility and crystalline form). However, there is no
change in position of the solubility boundary formed once the
initial formation of aggregates (with inverted solubility) at a
particular temperature has been established over several days.
The solubility boundary can be shifted to lower concentrations by
decreasing the temperature at which the initial aggregates are
formed, which decreases the concentration of aggregated particles
formed before crystallization proceeds on the surface (Fig. 4). No
crystallization of protein in the bulk is observed and nucleation
appears to proceed heterogeneously on the surface of the pre-
formed aggregates only. Hence the behavior of the double mutant
is controlled by the kinetics of the crystallization process (which
would also hold true for the P23VR36S mutant). The relative
concentrations of either aggregate or crystal are defined both by
the phase boundary of the initial single mutant driving that
behaviour, but also by the rate at which that particular condensed
phase forms. While this would explain why the solubility line lies
between those of the single mutants, the data does imply that the
aggregated material is as thermodynamically stable as the crystal.
Conventional thought suggests that the entropy loss due to
condensation is balanced by the decrease in free energy due to
the formation of contacts in the crystal. The number of contact
points in the crystal should also be higher than in the amorphous
aggregate, making the crystal the most thermodynamically stable
form. It is of course possible that the aggregated material is
kinetically trapped and would eventually crystallise resulting in
liquidus line similar to the R58H single mutant if given sufficient
time. However, the original work on the P23V single mutant did
demonstrate that aggregated and crystalline material had the
same solubility line. The phase diagram for this double mutant
Fig. 5 Temperature dependence on solubility for single and double
mutants of HGD.
Table 1 Values of the parameters S, the slope for Dmtrans/kT0 vs. T/T0 and
V the intercept at T = T0 = 303 K for each protein
Protein S V K = V  S
HGD 19 4.4 23.4
P23V 20 5.1 14.9
P23T 28 7.6 20.4
R36S 10 6.9 16.9
P23VR36S 7.5 6.8 14.3
P23TR36S (normal) 7.3 6.5 13.8
P23TR36S (inverted) 24 7.8 16.2
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seems consistent with that view and we believe that in fact
the monomer–aggregate–crystal co-existence is an equilibrium
arrangement.
Double mutants as a means to examine protein anisotropy
This work offers important insights into the factors driving the
self-assembly of proteins mediated by anisotropic interactions.
The formation of new crystal contacts is considered a driving
force in promoting protein crystallization.38 For some proteins
this is likely to be true, but for the four individual mutant
proteins described here, only the R36S mutant forms a new
crystal contact. It is possible that new crystal contacts are
formed in the double mutants that do not exist in the single
mutants. However there is a remarkable preservation in the
position of the phase boundaries for each condensed phase
formed in the double mutants when compared to the single
mutant form, which suggests that the existing contact points
are maintained. Based on the P23VR36S mutant alone, it would
appear that the crystal contact formed by the R36S substitution
is dominating the behaviour of the double mutant. The phase
diagram for the P23VR58H mutant however would suggest that
this might just be a kinetic effect. The R36S-type crystal forms
most quickly and it is never possible to obtain protein concen-
trations high enough to form the aggregates associated with the
P23V mutant, but these are observed in the P23VR58H mutant
since crystallization is sufficiently slow to allow the faster
aggregation process to occur. Of course, X-ray analysis of the
double mutants will be required to confirm this. X-ray struc-
tures for the native protein and the R36S, R58H and P23T single
mutants of the protein are known and have been discussed in
some detail.30–37 For each single and double mutant described
here, no major change in protein structure is observed upon
mutagenesis. Symmetry is a further matter to consider.18 There-
fore, the factors controlling the crystallization and, more
widely, the self-assembly of proteins are complex and will
depend on a combination of influences including solution
conditions, the formation of crystal contacts and symmetry
which are of course influenced strongly by the protein aniso-
tropy. These directional interactions, as a consequence of the
microscopic surface features of the protein, complicate efforts
to manipulate protein–protein interactions to facilitate crystal-
lization and have been difficult to explore systematically until
now. Screening a range of solution conditions to find those
suitable for crystallization are often unsuccessful, even for
closely homologous proteins.16 Other strategies to improve
the success rate of crystallization by surface engineering of
proteins using surface-energy reduction (SER) have had suc-
cess.16 For the double mutants created here, no screening of
solutions conditions was required and the amino acids selected
for mutagenesis were chosen on the basis of the impact a single
mutation had on the phase behavior of the protein. Hence, this
is a new approach, which has produced from three attempts,
three proteins for which the equilibrium solubility lines are
preserved in the double mutant and are qualitatively (and semi-
quantitatively) predicted.
Experimental section
Materials and methods
Analytical grade sodium hydroxide, sodium chloride, glacial
acetic acid, sodium phosphate dibasic heptahydrate, sodium
dihydrogen phosphate dihydrate and sodium azide used for the
preparation of buffers were purchased from Fisher Scientific
(Dublin, Ireland), and used without further purification. All
buffers were prepared in Milli-Q water and adjusted to the
correct pH using sodium hydroxide or HCl as appropriate.
Molecular cloning, site-directed mutagenesis, expression and
purification of recombinant proteins
Recombinant HGD was prepared by amplification of the coding
sequence from a human fetal lens cDNA library, over-expressed
in E. coli (BL21-Gold (DE3) competent cells, Stratagene, USA),
isolated and purified as reported previously.30 Oligonucleotide
primers for the desired mutations were synthesized by Life
Technologies (Dublin, Ireland). Mutagenesis was performed with
QuikChange II site-directed mutagenesis kit from Stratagene
(USA) using DNA primers and HGD wild type plasmid DNA
isolated and purified by using QIAGEN plasmid purification
midi kit (Qiagen GmbH, Hilden, Germany). Each of the three
double mutant plasmids obtained after mutagenesis were
sequenced with the T7 promoter primer by using an automated
capillary DNA sequencer (MRCPPU, College of Life Sciences,
University of Dundee, Scotland) and was found to contain the
desired mutations. Three mutant proteins (P23VR36S, P23TR36S
and P23VR58H), each containing two amino acid substitutions
were expressed and purified by the same methodology as for
HGD.30
Characterization of mutant proteins
For each mutant protein, SDS-PAGE and size exclusion HPLC were
used to confirm protein purity at 498%. The intact molecular
weight for the mutant proteins were analysed by electrospray
ionization mass spectrometry (Finger Prints Proteomics Facility,
College of Life Sciences, University of Dundee), which confirmed
molecular mass of 20607 Da for HGD, 20539 1 Da for P23VR36S,
20541  1 Da for P23TR36S and 20589  1 Da for P23VR58H.
These mass values are consistent with those expected for these
amino acid substitutions. Circular dichroism (CD) spectra were
recorded on a JASCO J-810 spectropolarimeter (University of
Glasgow, Scotland). Near-UV CD spectra were measured and
normalized with respect to protein concentration; far-UV CD
spectra were measured and normalized with respect to the
concentration of the backbone peptide bonds.
Solubility measurements (liquidus lines)
Protein solutions were prepared initially by diafiltration against
100 mM sodium phosphate buffer containing 20mMDTT, pH 7.0
using Ultracel 10 kDa ultrafiltration discs (Merck Millipore, Co.
Cork, Ireland). Protein concentrations for the double mutants
were determined by UV absorbance using the extinction coeffi-
cient value of 2.09 mg1 ml cm1 after filtration through 0.22 mm
Millex-GV Millipore (Merck Millipore, Co. Cork, Ireland) syringe
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driven filter units. When required, protein solutions were
further concentrated by ultrafiltration using Amicon Ultra-4
centrifugal filter units (Merck Millipore, Co. Cork, Ireland) and
the protein concentration re-established by UV absorbance.
Crystallization/aggregation was allowed to proceed under
the relevant conditions for each mutant protein and the liquidus
lines weremeasured. The liquidus lines for P23VR36S, P23TR36S
and P23VR58H were measured as described previously.31 Protein
crystals of the double mutants P23VR36S, P23TR36S and
P23VR58H formed over a time period of 12 hours were allowed
to settle and then separated from the supernatant. The crystals
were dispersed in fresh buffer and stirred at a constant tempera-
ture to ensure uniformmixing. Every point on the solubility line is a
measure of the protein monomer concentration monitored over a
time period of 24–48 hours that has attained equilibrium with the
protein crystals in solution (i.e. until there are no further changes in
protein concentration). Phase diagrams were drawn using Origin
v6.1 software.
Imaging
Protein crystals were imaged by phase contrast and polarization
microscopy. An Olympus BX61 microscope with either 60 or
100 magnification oil-immersion lens were utilized for visual
observation of the protein crystals formed. The images were
then recorded using CellF software and image analysis was
performed using ImageJ software.
Conclusions
This work suggests a mechanism by which protein anisotropic
(or aeolotopic) interactions can be probed in a systematic
manner. This type of data is critical if good molecular models
to predict protein behavior are to be developed. For the P23TR36S
mutant, we created a protein, which forms two different crystal
types, one that melts when the solution is heated and one that
melts when the solution is cooled, with co-existence of the two
crystal forms at 303 K, the point at which the individual liquidus
lines for the single mutant variants overlap. This observation is
unprecedented. On a broader level, this work is a starting point
which will require a combination of further experiments and
complementary simulations to more clearly understand the inter-
play between the complex, competing forces controlling protein
self-assembly and crystallization. However, it is clear that the
surface characteristics of the protein, defined by the surface
amino acids, can lead to a variety of condensed phases for
the same protein. A change in the external environment, e.g.
temperature, results in some amino acids contributing more to
the protein self-assembly behaviour than others, leading to the
variety of structures that we observe. For these three double
mutants, we can conclude the following. The positions of the
phase boundaries in the double mutants are predicted on the
basis of the relative thermodynamic stabilities of the individual
single mutants (i.e. the mutant with lowest solubility at particular
point on the phase diagram will dominate), with one exception.
If it is possible to form both phases under the same solution
conditions, the kinetics of the condensed phase that forms first
will determine the position of the equilibrium solubility line of
the double mutant. The kinetics for the formation of each phase
in the double mutant can be predicted if the kinetics for each
single mutant is known.
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